Workflow
AVANCE® (acellular nerve allograft–arwx)
icon
Search documents
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Axogen (NASDAQ:AXGN), Addex Therapeutics (NASDAQ:ADXN)
Benzinga· 2025-12-04 09:48
Group 1: UiPath Financial Performance - UiPath Inc. reported third-quarter adjusted earnings of 16 cents per share, surpassing the Street estimate of 15 cents per share [1] - The company's quarterly revenue reached $411.11 million, exceeding the consensus estimate of $392.97 million and showing an increase from $354.65 million in the same period last year [1] Group 2: Stock Market Reaction - Following the positive financial results, UiPath shares rose 8.7% to $16.18 in pre-market trading [2]